From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...
Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...
Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
"We found no evidence to support exenatide as a disease-modifying treatment for people with Parkinson's disease," researchers ...
Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation ...